Table 3.
Adverse effects reported by healthcare providers from patients seeking medical care after synthetic cathinone use
| James [1] | MMWR [13] | Regan [35] | EMCDDA [30] | Total | |
|---|---|---|---|---|---|
| # patients | 149 | 35 | 57 | 72 | 313 |
| Cardiac | 113 | 30 | 26 | 63 | 293 |
| Psychiatric | 84 | 44 | 37 | 28 | 193 |
| Neurologic | 56 | 18 | 26 | 9 | 109 |
| Gastrointestinal | 27 | NA | 3 | 10 | 40 |
| Pulmonary | 13 | NA | 10 | NA | 23 |
| Ear, nose and throat | 7 | NA | 7 | NA | 14 |
| Other | 48 | NA | 8 | NA | 56 |
It is possible that these effects are not all related to cathinone use. Only a few of these cases were analytically confirmed as synthetic cathinone exposures. Additionally, many other substances such as ethanol and other drugs of abuse were reported or found on drug screening